Cancer-Associated Fibroblasts Modulate Transcriptional Signatures Involved in Proliferation, Differentiation and Metastasis in Head and Neck Squamous Cell Carcinoma.

FMOD HNSCC MMP9 cDNA microarray cancer-associated fibroblasts overall survival

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
04 Jul 2021
Historique:
received: 03 05 2021
revised: 21 06 2021
accepted: 30 06 2021
entrez: 20 7 2021
pubmed: 21 7 2021
medline: 21 7 2021
Statut: epublish

Résumé

Cancer-associated fibroblasts (CAFs) are known to increase tumor growth and to stimulate invasion and metastasis. Increasing evidence suggests that CAFs mediate response to various treatments. HNSCC cell lines were co-cultured with their patient-matched CAFs in 2D and 3D in vitro models, and the tumor cell gene expression profiles were investigated by cDNA microarray and qRT-PCR. The mRNA expression of eight candidate genes was examined in tumor biopsies from 32 HNSCC patients and in five biopsies from normal oral tissue. Differences in overall survival (OS) were tested with Kaplan-Meier long-rank analysis. Thirteen protein coding genes were found to be differentially expressed in tumor cells co-cultured with CAFs in 2D and 81 in 3D when compared to tumor cells cultured without CAFs. Six of these genes were upregulated both in 2D and 3D (

Identifiants

pubmed: 34283070
pii: cancers13133361
doi: 10.3390/cancers13133361
pmc: PMC8269044
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Swedish Cancer Foundation
ID : 2017/301; 2020/0738

Références

Lung Cancer. 2004 Aug;45 Suppl 2:S163-75
pubmed: 15552797
J Oral Maxillofac Surg. 2015 Dec;73(12):2334-42
pubmed: 26117378
J Oncol. 2009;2009:305908
pubmed: 20066159
Biomed Res Int. 2014;2014:802841
pubmed: 24949470
Curr Opin Genet Dev. 2009 Feb;19(1):67-73
pubmed: 19211240
Oncol Lett. 2016 Aug;12(2):783-787
pubmed: 27446351
FEBS J. 2011 Jan;278(1):16-27
pubmed: 21087457
Prog Nucleic Acid Res Mol Biol. 1994;47:29-80
pubmed: 8016323
Ther Clin Risk Manag. 2018 Feb 19;14:295-303
pubmed: 29497306
Clin Otolaryngol Allied Sci. 1996 Oct;21(5):429-38
pubmed: 8932948
Semin Cell Dev Biol. 2010 Feb;21(1):33-9
pubmed: 19896548
Oncotarget. 2016 May 3;7(18):25742-54
pubmed: 27013588
Front Biosci. 2006 May 01;11:1696-701
pubmed: 16368548
World J Surg Oncol. 2016 Nov 29;14(1):297
pubmed: 27894325
Onco Targets Ther. 2015 Jul 03;8:1619-26
pubmed: 26170698
Head Neck. 2020 Mar;42(3):569-584
pubmed: 31750584
Nat Rev Drug Discov. 2014 Dec;13(12):904-27
pubmed: 25376097
Carcinogenesis. 2013 Jun;34(6):1286-95
pubmed: 23358854
Dev Dyn. 2001 Dec;222(4):667-80
pubmed: 11748835
J Clin Invest. 2004 Aug;114(4):569-81
pubmed: 15314694
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Cell. 2005 May 6;121(3):335-48
pubmed: 15882617
J Enzyme Inhib Med Chem. 2019 Dec;34(1):420-428
pubmed: 30734598
Int J Cancer. 2008 Nov 15;123(10):2229-38
pubmed: 18777559
BMC Cancer. 2009 Oct 18;9:370
pubmed: 19835631
Oral Oncol. 2015 Jan;51(1):24-30
pubmed: 25456005
Mol Genet Genomic Med. 2019 Aug;7(8):e857
pubmed: 31304688
Nature. 2002 Jan 31;415(6871):530-6
pubmed: 11823860
Eur J Cell Biol. 2013 Jan;92(1):1-11
pubmed: 23058688
Clin Cancer Res. 2021 May 1;27(9):2636-2647
pubmed: 33622705
Nat Med. 2015 Jan;21(1):62-70
pubmed: 25419707
Nat Rev Cancer. 2006 May;6(5):392-401
pubmed: 16572188
Int J Mol Sci. 2021 Feb 15;22(4):
pubmed: 33671869
Oncol Lett. 2018 May;15(5):7497-7505
pubmed: 29725456
Mol Cancer Res. 2012 Sep;10(9):1158-68
pubmed: 22809838
J Oral Pathol Med. 2011 Feb;40(2):127-34
pubmed: 20969624
Biomed Pharmacother. 2017 Mar;87:539-547
pubmed: 28081464
Front Mol Biosci. 2019 Aug 13;6:70
pubmed: 31475157
Cancer Biol Ther. 2008 Aug;7(8):1250-61
pubmed: 18487950
Nucleic Acids Res. 2016 Jul 8;44(W1):W147-53
pubmed: 27190236
J Oral Pathol Med. 2013 Jan;42(1):26-36
pubmed: 22643066
Cancer Res. 2001 Aug 15;61(16):5974-8
pubmed: 11507037
Nat Rev Cancer. 2004 Sep;4(9):737-47
pubmed: 15343280
Breast Cancer Res. 2011 Jul 26;13(4):214
pubmed: 21867572
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Cancer Cell Int. 2020 Dec 22;20(1):599
pubmed: 33353547
J Clin Exp Dent. 2016 Apr 01;8(2):e130-5
pubmed: 27034751
Oncogenesis. 2018 Oct 5;7(10):78
pubmed: 30287850
Cancers (Basel). 2021 Feb 06;13(4):
pubmed: 33562096
Cancer Microenviron. 2008 Dec;1(1):69-83
pubmed: 19308686
Mol Hum Reprod. 2005 Jul;11(7):489-94
pubmed: 16123076
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13784-9
pubmed: 11707590
Br J Cancer. 2020 Sep;123(6):988-999
pubmed: 32572171
Oncol Lett. 2017 Jun;13(6):4475-4480
pubmed: 28599447
Clin Cancer Res. 2009 Nov 1;15(21):6630-8
pubmed: 19843665
PLoS One. 2012;7(8):e42264
pubmed: 22870311

Auteurs

Emilia Wiechec (E)

Division of Cell Biology, Department of Biomedical and Clinical Sciences, Linköping University, 58185 Linköping, Sweden.

Mustafa Magan (M)

Division of Cell Biology, Department of Biomedical and Clinical Sciences, Linköping University, 58185 Linköping, Sweden.

Natasa Matic (N)

Division of Cell Biology, Department of Biomedical and Clinical Sciences, Linköping University, 58185 Linköping, Sweden.
Department of Otorhinolaryngology in Linköping, Anesthetics, Operations and Specialty Surgery Center, Region Östergötland, 58185 Linköping, Sweden.

Anna Ansell-Schultz (A)

Division of Cell Biology, Department of Biomedical and Clinical Sciences, Linköping University, 58185 Linköping, Sweden.

Matti Kankainen (M)

Translational Immunology Research Program and Department of Clinical Chemistry, University of Helsinki, 00290 Helsinki, Finland.
Department of Medical and Clinical Genetics, University of Helsinki, Helsinki University Hospital, 00029 Helsinki, Finland.
iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, 00014 Helsinki, Finland.

Outi Monni (O)

iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, 00014 Helsinki, Finland.
Applied Tumor Genomics Research Program and Department of Oncology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.

Ann-Charlotte Johansson (AC)

Division of Cell Biology, Department of Biomedical and Clinical Sciences, Linköping University, 58185 Linköping, Sweden.

Karin Roberg (K)

Division of Cell Biology, Department of Biomedical and Clinical Sciences, Linköping University, 58185 Linköping, Sweden.
Department of Otorhinolaryngology in Linköping, Anesthetics, Operations and Specialty Surgery Center, Region Östergötland, 58185 Linköping, Sweden.

Classifications MeSH